Theme
AI drug discovery
Machine learning applied to drug discovery and development.
AI drug discovery applies machine learning to target identification, molecule design, and clinical development to compress timelines and cost. The approach spans physics-based simulation, generative models, and large-scale biological and clinical datasets.
Companies · 8
9181
Tempus AI, Inc.TEM
Market cap$13B
Conviction4 / 5
AI drug discovery
Read profileXaira Therapeutics, Inc.Private
Market cap—
Conviction4 / 5
AI drug discovery
Read profileSchrödinger, Inc.SDGR
Market cap$1.9B
Conviction3 / 5
AI drug discovery
Read profileIllumina, Inc.ILMN
Market cap$39B
Conviction3 / 5
AI drug discovery
Read profileIsomorphic Labs LimitedPrivate
Market cap—
Conviction3 / 5
AI drug discovery
Read profileRecursion Pharmaceuticals, Inc.RXRX
Market cap$2.0B
Conviction3 / 5
AI drug discovery
Read profileModerna, Inc.MRNA
Market cap$73B
Conviction3 / 5
AI drug discovery
Read profileAbsci CorporationABSI
Market cap$1.7B
Conviction1 / 5
AI drug discovery
Read profile